171 related articles for article (PubMed ID: 37752235)
1. Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer.
Advani R; Luzzi S; Scott E; Dalgliesh C; Weischenfeldt J; Munkley J; Elliott DJ
Oncogene; 2023 Oct; 42(43):3161-3168. PubMed ID: 37752235
[TBL] [Abstract][Full Text] [Related]
2. Androgen-regulated transcription of
Munkley J; Li L; Krishnan SRG; Hysenaj G; Scott E; Dalgliesh C; Oo HZ; Maia TM; Cheung K; Ehrmann I; Livermore KE; Zielinska H; Thompson O; Knight B; McCullagh P; McGrath J; Crundwell M; Harries LW; Daugaard M; Cockell S; Barbosa-Morais NL; Oltean S; Elliott DJ
Elife; 2019 Sep; 8():. PubMed ID: 31478829
[TBL] [Abstract][Full Text] [Related]
3. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.
Freytag M; Kluth M; Bady E; Hube-Magg C; Makrypidi-Fraune G; Heinzer H; Höflmayer D; Weidemann S; Uhlig R; Huland H; Graefen M; Bernreuther C; Wittmer C; Tsourlakis MC; Minner S; Dum D; Hinsch A; Luebke AM; Simon R; Sauter G; Schlomm T; Möller K
BMC Cancer; 2020 Dec; 20(1):1220. PubMed ID: 33339518
[TBL] [Abstract][Full Text] [Related]
4. Downregulated ESRP1/2 promotes lung metastasis of bladder carcinoma through altering FGFR2 splicing and macrophage polarization.
Zhao Y; Li M; Wu W; Miao W; Liu H
Front Immunol; 2023; 14():1161273. PubMed ID: 37090731
[TBL] [Abstract][Full Text] [Related]
5. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms.
Ishii H; Saitoh M; Sakamoto K; Kondo T; Katoh R; Tanaka S; Motizuki M; Masuyama K; Miyazawa K
J Biol Chem; 2014 Oct; 289(40):27386-99. PubMed ID: 25143390
[TBL] [Abstract][Full Text] [Related]
6. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells.
Jeong HM; Han J; Lee SH; Park HJ; Lee HJ; Choi JS; Lee YM; Choi YL; Shin YK; Kwon MJ
Oncogenesis; 2017 Oct; 6(10):e389. PubMed ID: 28991261
[TBL] [Abstract][Full Text] [Related]
7. A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal Breast Cancer.
Elhasnaoui J; Ferrero G; Miano V; Franchitti L; Tarulli I; Coscujuela Tarrero L; Cutrupi S; De Bortoli M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887187
[TBL] [Abstract][Full Text] [Related]
8. The epithelial splicing factors ESRP1 and ESRP2 positively and negatively regulate diverse types of alternative splicing events.
Warzecha CC; Shen S; Xing Y; Carstens RP
RNA Biol; 2009; 6(5):546-62. PubMed ID: 19829082
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Epithelial Splicing Regulatory Protein 1 in Metastatic Lesions of Serous Ovarian Carcinoma Correlates with Poor Patient Prognosis.
Lu X; Li R; Wang X; Guo Q; Wang L; Zhou X
Cancer Biother Radiopharm; 2022 Nov; 37(9):850-861. PubMed ID: 34495766
[No Abstract] [Full Text] [Related]
10. Ablation of the epithelial-specific splicing factor Esrp1 results in ureteric branching defects and reduced nephron number.
Bebee TW; Sims-Lucas S; Park JW; Bushnell D; Cieply B; Xing Y; Bates CM; Carstens RP
Dev Dyn; 2016 Oct; 245(10):991-1000. PubMed ID: 27404344
[TBL] [Abstract][Full Text] [Related]
11. Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.
Deloria AJ; Höflmayer D; Kienzl P; Łopatecka J; Sampl S; Klimpfinger M; Braunschmid T; Bastian F; Lu L; Marian B; Stättner S; Holzmann K
Oncotarget; 2016 Nov; 7(45):73800-73816. PubMed ID: 27650542
[TBL] [Abstract][Full Text] [Related]
12. Epithelial Splicing Regulatory Protein 1 Is Overexpressed in Breast Cancer and Predicts Poor Prognosis for Breast Cancer Patients.
Liu X; Wang Q; Song S; Feng M; Wang X; Li L; Liu Y; Shi C
Med Sci Monit; 2021 Jul; 27():e931102. PubMed ID: 34262011
[TBL] [Abstract][Full Text] [Related]
13. Role of epithelial splicing regulatory protein 1 in cancer progression.
Kwon MJ
Cancer Cell Int; 2023 Dec; 23(1):331. PubMed ID: 38110955
[TBL] [Abstract][Full Text] [Related]
14. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
15. Splicing factor
Gökmen-Polar Y; Neelamraju Y; Goswami CP; Gu Y; Gu X; Nallamothu G; Vieth E; Janga SC; Ryan M; Badve SS
EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30665944
[TBL] [Abstract][Full Text] [Related]
16. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
Göttgens EL; Span PN; Zegers MM
Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
[TBL] [Abstract][Full Text] [Related]
17. The global Protein-RNA interaction map of ESRP1 defines a post-transcriptional program that is essential for epithelial cell function.
Peart NJ; Hwang JY; Quesnel-Vallières M; Sears MJ; Yang Y; Stoilov P; Barash Y; Park JW; Lynch KW; Carstens RP
iScience; 2022 Oct; 25(10):105205. PubMed ID: 36238894
[TBL] [Abstract][Full Text] [Related]
18. Esrp1-Regulated Splicing of Arhgef11 Isoforms Is Required for Epithelial Tight Junction Integrity.
Lee S; Cieply B; Yang Y; Peart N; Glaser C; Chan P; Carstens RP
Cell Rep; 2018 Nov; 25(9):2417-2430.e5. PubMed ID: 30485810
[TBL] [Abstract][Full Text] [Related]
19. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing.
Warzecha CC; Sato TK; Nabet B; Hogenesch JB; Carstens RP
Mol Cell; 2009 Mar; 33(5):591-601. PubMed ID: 19285943
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing regulates distinct subcellular localization of Epithelial splicing regulatory protein 1 (Esrp1) isoforms.
Yang Y; Carstens RP
Sci Rep; 2017 Jun; 7(1):3848. PubMed ID: 28634384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
